Tag: bioequivalence

post-image
Apr, 11 2026

Why Complex Generic Drugs Are Harder to Get FDA Approval

Discover why complex generic drugs face higher FDA rejection rates, from bioequivalence hurdles to drug-device challenges and the costly 505(b)(2) pathway.
post-image
Mar, 18 2026

Generic Drugs: Complete Definition and Core Characteristics

Generic drugs contain the same active ingredients as brand-name medications and are proven to be equally safe and effective. They save patients and the healthcare system billions each year while meeting the same strict FDA standards.
post-image
Feb, 7 2026

Why Generic Switching Raises Concerns for NTI Drugs

Generic substitution for NTI drugs can cause dangerous shifts in drug levels, leading to toxicity or treatment failure. Warfarin, phenytoin, lithium, and other narrow therapeutic index drugs require careful monitoring - and often, no substitution at all.